Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-03-03 | 2020-01-20 |
| Drug Identification Number | 02265990 | 02265990 |
| Brand name | VINORELBINE INJECTION | VINORELBINE INJECTION |
| Common or Proper name | Vinorelbine Injetion | Vinorelbine Injetion |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | VINORELBINE | |
| Strength(s) | 10MG | |
| Dosage form(s) | SOLUTION | |
| Route of administration | INTRAVENOUS | |
| Packaging size | 1 ml | 1 ml |
| ATC code | L01CA | |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2020-01-20 | |
| Actual start date | 2017-12-14 | |
| Estimated end date | 2021-11-29 | 2020-03-31 |
| Actual end date | 2021-06-01 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Old DIN has been moved to Dormant- New DIN (02511347) to be made available November 29, 2021 | Not Available |
| Health Canada comments |